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ecent developments in brachytherapyrachytherapy has a long and illustrious history in the treat-
ent of cancer dating back to the early 20th century. Although
ts popularity has ﬂuctuated in response to the emergence of
ewer treatmentmodalities, brachytherapy has persisted over
ime. Although it is not the predominant radiotherapy modal-
ty, this treatment modality continues to play an important
ole in cancer therapy, even now, more than a 100 years after
t was ﬁrst introduced. Today, it is most commonly used in
rostate, gynecological, and breast cancer, although techno-
ogical developments in recent years have opened up several
ew treatment possibilities.
Brachytherapy tends to “ﬂy under the radar” when
ompared to external beam radiotherapy (EBRT). However,
umerous important – though perhaps under-appreciated –
dvances in brachytherapy have been made in the last two
ecades. This therapeutic modality has several important
dvantages, particularly the fact that it allows for high-doses
f radiation to be delivered to the tumor with a high degree
f precision, thus minimizing damage to healthy tissue. For
his reason, it is important that efforts be made to remind all
ancer care professionals of the continuous improvements in
his technique and the value of brachytherapy in the cancer
reatment toolkit.
In the last few years, our journal, Reports of Practi-
al Oncology and Radiotherapy (RPOR), has been publishing
utting-edge research into new developments in the ﬁeld
f brachytherapy, particularly in improved dosimetric tech-
iques, imaging, and treatments. In this editorial, we take a
loser look at a few of these advances through some of the
ore relevant papers published in our journal over the past 3
ears. We believe that these important papers help to reveal
he value and progress that is being made in the ﬁeld, and
e are proud to be able to help disseminate this important
esearch to a wide audience.
. Imagingunctional imaging for brachytherapy is an area in which
reat improvements have been made. The range of imag-
ng tools, many which can now be used in real-time, have
reatly expanded the possibilities of brachytherapy. Theseincludeultrasound, power doppler imaging, positron emission
tomography (PET), and magnetic resonance imaging (MRI).
The combination of functional imaging with intraoperative
dose calculation and optimization opens new horizons for
brachytherapy.
Thanks in large part to advances in computer technology,
treatment planning, intraoperativenavigation, anddosedeliv-
ery have all improved. Powerful newcomputers able to process
images in real-time have made image-guided brachytherapy
(IGBT) the technique of choice to achieve excellent conformal
radiation therapy. IGBT allows for accurate dose delivery to
small volumes under direct image visualization.
1.1. An example of IGBT is the paper published in
RPOR in 2008 with the following title: “Real-time
brachytherapy for prostate cancer – implant analysis”1
This article evaluated the use of real-time techniques to carry
out seed implants in prostate BT. The authors discuss how
high-dose rate brachytherapy (HDR-BT) has become one of the
more popular methods in early-stage prostate cancer because
dwell times inside the catheter can be individually selected
(optimized) for better targeting while sparing normal tissue
and organs at risks. In their study, the authors used transrec-
tal ultrasound guidance for continuous visualization of the
prostate during treatment planning. However, as the authors
point out, precision of catheter implantation based on the pre-
planned needle positioning and patient anatomy is essential.
This research is important because, as the authors state, few
studies have addressed the subject of needle displacement
andpossible adverse consequences. Theauthors suggest steps
that can be taken during the needle insertion procedure to
improve the quality of the ﬁnal dose distribution.
2. Dosimetric researchRPOR has a strong tradition in the physics of radiation ther-
apy, andnumerous articles have beenpublished in this journal
over the years on this subject. Below, we discuss some of the
most important reports.
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2.1. Application of Monte Carlo calculations for
validation of a treatment planning system in high dose
rate brachytherapy2
In 2009, Neseri and Mezbahi reported the results of their study
which investigated the use of Monte Carlo calculations to val-
idate a treatment planning system in HDR-BT. In that article,
the authors discuss the importance of accurately calculating
the absorbed dose distribution in a patient before treatment,
which is particularly important in HDR due to the high dose
rate and dose per session as any inaccuracies in dose dis-
tributions can have severe consequences on healthy tissue.
The authors wanted to verify the accuracy of algorithms used
in HDR BT treatment planning for 3 different 60Co sources
of the GZP6 afterloading brachytherapy system. They found
that dose calculations of the TPS were accurate and so val-
idated using the Monte Carlo method. The agreement (<2%)
between TPS and MC calculated dose distributions was good
and this study conﬁrmed the accuracy of TPS calculated dose
distributions for clinical use in HDR brachytherapy.
2.2. Dosimetric veriﬁcation of dose optimisation
algorithm during endovascular brachytherapy of the
peripheral vessels3
In this study, Zwierzchowski et al. performed a dosi-
metric veriﬁcation of dose optimization algorithm during
endovascular brachytherapy following angioplasty. Endovas-
cular brachytherapy has long been used to treat recurrent
vessel narrowing due to restenosis following angioplasty. The
aim of endovascular brachytherapy in these case is to pre-
vent inward remodelling and increase the lumen area. As
the authors point out, endovascular brachytherapy has been
shown to signiﬁcantly reduce the risk of restenosis if the
irradiation is planned and delivered accurately. The difﬁculty
lies in dose veriﬁcation, which is difﬁcult because endovas-
cular in vivo dose checks are practically impossible. As an
alternative, the authors designed and constructed a phantom
which allowed for reliable and repeatable dosimetric veriﬁ-
cation (using thermoluminescent detectors and Gafchromic
ﬁlms). The results conﬁrmed the accuracy of the calculation
algorithm in endovascular brachytherapy conditions. Impor-
tantly, the end result of this study was the creation of indices
that can be used to describe dose homogeneity around the
applicator in endovascular brachytherapy. Through optimiza-
tion, the authors were able to increase dose homogeneity by
30%at the edges andby7% in themiddle of the treatedvolume.
2.3. Dosimetric veriﬁcation of the dose calculation
algorithms in real time prostate brachytherapy4
In this study, Mocna and Zwierzchowsky evaluated 3 opti-
mization algorithms [geometric optimization (GO), inverse
optimization (IO) and blind inverse optimization (BIO)] used
to modulate dwell times and source positioning in real time
prostate brachytherapy. This study was important because
dwell times and source positioning have a direct impact on
dose distribution and, therefore, therapeutic indices. In their
study, the authors used a phantom for the dosimetric veri-
ﬁcation. They compared doses measured by semiconductoriotherapy 1 6 ( 2 0 1 1 ) 203–206
detectors and calculated doses and found differences ranging
from 0.10Gy in the urethra for IO and BIO and up to 2.46Gy
for GO. Differences in the rectum were much smaller, ranging
from 0.32 and 0.66Gy. The authors concluded that the use of a
phantom ensures repeatable geometric relations between the
needles, the treated volume, and the corresponding organs
at risk and also makes dose distribution veriﬁcation possible.
The important “take-away” conclusion is that it is essential
to understand the limitations of optimization algorithms to
makeproper clinical decisions during real-timebrachytherapy
of the prostate.
2.4. Veriﬁcation in the water phantom of the
irradiation time calculation done by the algorithm used in
intraoperative radiotherapy5
In this study, the authors evaluated dose calculations used in
intraoperative radiation therapy (IORT) for breast-conserving
treatment. According to the authors, although irradiation time
is usually determinedmanually in IORT, automationof irradia-
tion time calculation is essential. They used a water phantom
to evaluate the accuracy of the Generalized Gaussian Pencil
Beam (GGPB) algorithm which is part of the Varian TPS. The
authors conclude that the GGPB algorithm is a tool that can be
used for IORT, not just for conventional radiotherapy. Results
calculated automatically were more reliable as well as easier
and faster to obtain.
2.5. Differential dose contributions on total dose
distribution of 125I brachytherapy source6
In this study, a group of researchers from Turkey assessed
how differences in source geometry and internal construc-
tion affect total dose distribution. According to the authors,
source models are highly manufacturer-speciﬁc and vary from
one another in weld thickness and type, radioactivity car-
rier construction, presence of radio-opaque material (sharp
or rounded edges), presence of silver (which produces charac-
teristic X-rays that modify the photon spectrum), and capsule
wall thickness. All of these properties can affect the dosimet-
ric characteristics of the source, and, as the authors argue, the
angular and radial dose distributions of the implanted source
are clinically relevant. The authors used aMonte Carlo simula-
tion because dose information of inner geometrical structure
of a brachytherapy source cannot be acquired by experimental
methods.
2.6. The histopathologic evaluation of soft tissue
changes in rabbit extremity after different
dose-fractionation schemes of interstitial high dose rate
(HDR) brachytherapy7
In this trial, the authors note that although HDR is the modal-
ity of choice in soft tissue sarcoma, there is a paucity of
prospective randomized clinical trials to investigate how var-
ious HDR dose-fractionation schemes affect normal tissue
damage. The trials in the literature are retrospective with lim-
ited number of patients and heterogeneous therapies. After
using three different fractionation schemes on 3 groups, the
authors found that fractionated interstitial HDR resulted in a
radio
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ower toxicity rate and less severe toxicity compared to a single
igh dose fraction. As a result, the authors suggest that radi-
tion oncologists need to be aware of the increased morbidity
elated to irreversible early toxicity or progressive late toxicity
efore using a single fractionated regimen in the clinic.
.7. In-air calibration of new high dose rate 60Co
rachytherapy sources: results of measurements on a
ZP6 brachytherapy afterloading unit8
ne of the more interesting advances in brachytherapy is
he production of artiﬁcial isotopes in recent decades, which,
hen combined with remote afterloading techniques, has led
o the increasing use of HDR techniques that are coming to
ominate brachytherapy. According to the authors, the dose
istributionwithin the target volumemust beuniform inorder
o achieve optimal tumor cell killing with uniform clonogenic
ell density and to avoid necrosis of healthy cells within the
arget volume. However this dose uniformity is difﬁcult to
chieve in interstitial HDR due to the very high radiation dose
n the vicinity of the radiation source. Hence, the tumor con-
rol probability (TCP) calculated on the basis of minimum or
ean or median target dose would not be appropriate to pre-
ict accurate treatment outcome. To solve this problem, the
uthors used in-air calibration. They conclude that this tech-
ique may offer an alternative approach to calculate TCP for
DR implants.
. Breast cancer
or many years now, the two most important localizations for
rachytherapy have been breast and prostate cancer, largely
ecause these are ideal localizations for brachytherapy treat-
ent and because they have a high incidence rate. In the
ection on dosimetric research above, several of the studies
ddressed aspects of dosimetry for prostate cancer. In this
ection, we highlight a few studies that focus on breast cancer.
.1. The role of high-dose-rate brachytherapy boost in
reast-conserving therapy: long-term results of the
ungarian National Institute of Oncology9
he Hungarian National Institute of Oncology published the
esults of their long-term study of HDR-BT as a boost fol-
owing surgery. According to the authors, the use of a boost
as traditionally been delivered through low-dose rate (LDR)
rachytherapy, electrons or photons. However, HDR-BT has
een growing but there is still some controversy still exists
egarding the optimal boost technique. For this reason, the
uthors performed a retrospective analysis of 100 patients
ho underwent breast-conserving surgery followed by radio-herapy and a HDR-BT boost. The authors concluded that
nterstitial HDR-BT boost yields a low incidence of late side
ffects with local tumor control rates that are similar to per-
utaneous boost techniques.therapy 1 6 ( 2 0 1 1 ) 203–206 205
3.2. CT-image based conformal high-dose-rate
brachytherapy boost in the conservative treatment of
stage I–II breast cancer – introducing the procedure10
Similar to the previous study, this trial sought to evaluate
HDR boost after surgery for stage I–II breast cancer. The
authors evaluated 58 female patients who underwent breast-
conserving surgery followed by whole breast irradiation and a
10Gyboost to the tumor bedwith interstitial HDR. The authors
conclude that, to reduce the possibility of a geographical miss,
CT-guided 3D HDR-BT is especially appropriate for patients
with a large breast volume, a deep-seated tumor bed, and in
patients at high risk of local relapse. The authors believe that,
in selected cases, better local control rates with fewer side
effects might be achieved with this technique.
3.3. Sole conformal perioperative interstitial
brachytherapy of early stage breast carcinoma using
high-dose rate afterloading: longer-term results and
toxicity11
The results of this study provide further support for the use
of accelerated partial breast irradiation (APBI) after breast-
conserving surgery, though for select cases. The authors
carried out a prospective study of 25 patients who underwent
lumpectomy followed by HDR-BT for APBI using three-
dimensional treatment planning. The results were good: at a
median follow-upof 44months, none of thewomenhaddevel-
oped in-ﬁeld breast recurrences, and only one patient had an
out-of-ﬁeld recurrence and another had distant metastasis.
There were no regional nodal recurrences. The only treatment
complications were hematoma and abscess in the tumor bed
after extirpation. All patients rated the overall cosmetic out-
come as excellent or good. The authors conclude that this
method is suitable alternative to whole-breast radiotherapy
for patients with small tumous (<3 cm in diameter) without
negative prognostic factors for local recurrence. The authors
do caution, however, that local disease control should be com-
pared with standard adjuvant radiotherapy in a randomized
clinical study.
3.4. Optimization in high-dose rate vaginal cylinder
for vaginal cuff irradiation12
American Brachytherapy Society guidelines onHDR treatment
for endometrial carcinoma suggest that a pre-calculated treat-
mentplan canbeused for patient treatmentdelivery.However,
the authors of this study argue that use of a pre-calculated
plan excludes the ability to compute the dose to the organs at
risk. By optimizing the treatment plan, it is possible to affect
the dose to the rectum and bladder. Two different HDR cylin-
der models, the non-curved dome model (NCDM) and curved
dome model (CDM), were studied. The authors found that the
CDM results in more uniform dose distribution around the
vaginal cylinder than NCDM. Importantly, they conclude that
dose distribution for all the vaginal cylinders can be stored as
a library plan and the best matched for target geometry can
be used for treatment.
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4. Conclusion
In conclusion, this journal believes that brachytherapy
deserves more attention as a valuable and highly improved
technique with unique advantages. The recent advent and
integration of sophisticated radiation planning and imag-
ing modalities has improved the quality of brachytherapy
treatments, allowing for more conformal radiation delivery.
Brachytherapy is an effective therapy formany types of cancer.
RPOR is pleased to be at the forefront of publishing meaning-
ful and serious articles on the latest ﬁndings in brachytherapy
research.
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